Immuron Limited is a biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the treatment of immune-mediated and infectious diseases. The company’s flagship product, Travelan, is FDA-approved for the prevention of travelers’ diarrhea. Immuron’s innovative technology and pipeline of products position it as a leader in the field of oral immunotherapy.
